| Literature DB >> 26785746 |
Takao Setoguchi1, Hirotaka Kawakami2, Yasuhiro Ishidou3, Hideki Kawamura4, Junichiro Nishi5, Takako Yoshioka6, Hironori Kakoi2, Satoshi Nagano2, Masahiro Yokouchi2, Akihide Tanimoto6, Setsuro Komiya2.
Abstract
BACKGROUND: Although most patients achieve favorable results following bipolar hip hemiarthroplasty (BHA), some experience rapid migration of the prosthesis. We retrospectively reviewed 18 patients with BHA that necessitated revision.Entities:
Mesh:
Year: 2016 PMID: 26785746 PMCID: PMC4719675 DOI: 10.1186/s12891-016-0876-3
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Clinicopathological data of the patients
Grey lines show asymptomatic PMN-positive groups
F Female, M Male, Fx Fracture, ION Idiopathic osteonecrosis of the femoral head, Prim. dis. Primary disease, Preop. diag. Preoperative diagnosis, asept. aseptic loosening, infect. infection, FBGD foreign body giant cell, particle particles, BMI body mass index, DM Diabetes mellitus, Palmo. pustu. Palmoplantar pustulosis, RA Rheumatoid arthritis, Neph. Synd. Nephrotic syndrome, ALC Alcoholic liver cirrhosis, C. I. Cerebral infarction, Epi. Epilepsy, athma. Bronchial asthma, Ca. Multiple cancer, WBC white blood cells
Clinicopathological data in which the differences between PMN-negative and PMN-positive patients
| Polymorphonuclear leukocytes | PMN-negative | PMN-positive |
|
|---|---|---|---|
| Presence of polyethylene debris or foreign body giant cell | 7/7 | 0/11 | <0.001 |
| Age (years, mean ± SD) | 61.7 ± 13.3 | 67.4 ± 15.6 | =0.779 |
| Female (%) | 0.57 | 0.64 | =0.783 |
| Body Mass Index (median) | 21.9 | 20.9 | =0.258 |
| Diabetes mellitus | 0/7 | 4/11 | =0.137 |
| Primary disease (ION:fracture) | 4:3 | 1:10 | =0.052 |
| W.B.C. (cells/mL, mean ± SD) | 6031 ± 1793 | 6497 ± 2382 | =0.664 |
Fig. 1Significant differences between PMN-positive and PMN-negative groups. a Kaplan–Meier analysis showed that BHA survival was significantly shorter in the PMN-positive than in the PMN-negative group. b CRP levels were significantly different between the PMN-positive and PMN-negative groups (p < 0.01). c JOA hip scores were significantly different between the PMN-positive and PMN-negative groups (p < 0.01)
Fig. 2Diagnostic criteria for PMN positivity
Fig. 3Significant differences between asymptomatic PMN-positive and PMN-negative groups. Asymptomatic PMN positivity was defined as a CRP level of <1 mg/dl and no local swelling, local heat, tenderness, or evidence of pus. a Kaplan–Meier analysis showed that BHA survival was significantly shorter in the asymptomatic PMN-positive than in the PMN-negative group. b CRP levels were significantly different between the asymptomatic PMN-positive and PMN-negative groups (p < 0.05). c JOA hip scores were significantly different between the asymptomatic PMN-positive and PMN-negative groups (p < 0.05)
Clinicopathological data in which the differences between PMN-negative and asymptomatic PMN-positive patients
| Polymorphonuclear leukocytes | PMN negative | Asymptomatic PMN-positive |
|
|---|---|---|---|
| Presence of polyethylene debris or foreign body giant cell | 7/7 | 0/4 | =0.003 |
| Age (years, median) | 61.0 | 62.0 | =0.850 |
| Female (%) | 0.57 | 0.50 | =0.652 |
| Body Mass Index (median) | 21.9 | 22.1 | =0.571 |
| Diabetes mellitus | 0/7 | 2/4 | =0.109 |
| Primary disease (ION:fracture) | 4:3 | 1:3 | =0.359 |
| W.B.C. (cells/mL, median) | 6770 | 7175 | =0.450 |
Fig. 4Diagnostic criteria for asymptomatic PMN positivity